Measles-containing-vaccine second-dose (MCV2) … MCV2, WUENIC in Belgium
Belgium: Measles-containing-vaccine second-dose (MCV2) immunization coverage was 73.0% in 2025. ◆ Volatile
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Belgium, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for measles-containing-vaccine second-dose (mcv2) immunization coverage in Belgium is 73.0%, measured in 2025.
That represents a change of down 11.0% on the previous year and down 9.9% over ten years.
Over the whole period, measles-containing-vaccine second-dose (mcv2) immunization coverage in Belgium peaked at 83.0% in 2009 and was at its lowest, 0.0%, in 2000.
That places Belgium 131st out of 194 countries with data for 2025, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Belgium, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 78.0% | — |
| 2007 | 78.0% | +0.0% |
| 2008 | 81.0% | +3.8% |
| 2009 | 83.0% | +2.5% |
| 2010 | 83.0% | +0.0% |
| 2011 | 83.0% | +0.0% |
| 2012 | 81.0% | -2.4% |
| 2013 | 81.0% | +0.0% |
| 2014 | 81.0% | +0.0% |
| 2015 | 81.0% | +0.0% |
| 2016 | 82.0% | +1.2% |
| 2017 | 82.0% | +0.0% |
| 2018 | 82.0% | +0.0% |
| 2019 | 82.0% | +0.0% |
| 2020 | 83.0% | +1.2% |
| 2021 | 83.0% | +0.0% |
| 2022 | 83.0% | +0.0% |
| 2023 | 82.0% | -1.2% |
| 2024 | 82.0% | +0.0% |
| 2025 | 73.0% | -11.0% |
Belgium compared with similar countries
- Belgium's 73.0% is below the median for high income countries, which is 92.0%, 79% of the median. (63 countries reporting)
- Belgium's 73.0% is below the median for Europe & Central Asia, which is 90.0%, 81% of the median. (51 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 32.0% | 0.0% | 83.0% | 10 |
| 2010s | 81.8% | 81.0% | 83.0% | 10 |
| 2020s | 81.0% | 73.0% | 83.0% | 6 |
Countries ranked near Belgium
More health data for Belgium
- Un projection of annual infant deaths, annual growth rate -3.28 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.2923 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,160 deaths per 1,000 people (2090)
- Number of infants who die before age 1 59 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.11 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0229 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.96 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is measles-containing-vaccine second-dose (mcv2) immunization coverage in Belgium?
- Measles-containing-vaccine second-dose (mcv2) immunization coverage in Belgium was 73.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Belgium?
- The highest recorded value was 83.0% in 2009.
- What is the lowest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Belgium?
- The lowest recorded value was 0.0% in 2000.
- How does Belgium rank for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Belgium ranks 131st out of 194 countries with data for 2025.
- Is measles-containing-vaccine second-dose (mcv2) immunization coverage rising or falling in Belgium?
- Over the last ten years it is down 9.9%. The long-run trend across the full record is volatile.
- Where does this Belgium data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).